NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1031220052

Registered date:10/05/2022

The efficiency of triflurigine for reccurence of colorectal liver metastasis.

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedLiver metastasis of colorectal cancer
Date of first enrollment28/07/2022
Target sample size30
Countries of recruitment
Study typeInterventional
Intervention(s)Operation, Trifluridine

Outcome(s)

Primary OutcomeProgression free survival at 2 years
Secondary OutcomeOverall survival at 2 years, Adverse events, Completion rate, Dose intensity, objective response rate, Recurrent type, R0 resection rate, Clavien-Dindo grade IIIa or higher complications

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximumNot applicable
GenderBoth
Include criteriaRecurrence after resection of liver metastasis of colorectal cancer
Exclude criteriaUnresectable extrahepatic metastasis

Related Information

Contact

Public contact
Name Ryota Ito
Address 3-1-3 Hongo,Bunkyo-ku,Tokyo 113-8431,Japan Tokyo Japan 113-8431
Telephone +81-3-3813-3111
E-mail r.ito.nh@juntendo.ac.jp
Affiliation Juntendo University Hospital
Scientific contact
Name Akio Saiura
Address 3-1-3 Hongo,Bunkyo-ku,Tokyo 113-8431,Japan Tokyo Japan 113-8431
Telephone +81-3-3813-3111
E-mail a-saiura@juntendo.ac.jp
Affiliation Juntendo University Hospital